Neuromyelitis optica in a patient with an early onset demyelinating episode: clinical and autoantibody findings.

Clin Neurol Neurosurg 2007 Dec;109(10):926-30

Department of Neurology, Charité-University Medicine, Charitéplatz 1, 10117 Berlin, Germany.

Recent clinical and laboratory findings have substantially advanced our understanding of neuromyelitis optica (NMO) as a humorally mediated, autoimmune disorder. We report on a patient who suffered a first episode of transverse myelitis at the age of 6 months following diphtheria-pertussis-tetanus (DPT) vaccination which had therefore been considered suggestive of acute disseminated encephalomyelitis (ADEM). Fifteen years later, the further disease course revealed typical NMO meeting all diagnostic criteria. This development points to a broad clinical and temporal heterogeneity of NMO, with ADEM probably occurring in the context of a shared autoimmune diathesis. Despite therapy response following B-cell depletion by rituximab, positive NMO-IgG autoantibody status remained unchanged, whereas direct testing for anti-aquaporin-4 (AQP-4)-antibodies was negative throughout. Our findings challenge the pathogenic relevance of NMO-IgG and indicate a varying diagnostic value of testing for NMO-IgG and AQP-4-autoantibodies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clineuro.2007.08.018DOI Listing
December 2007
20 Reads

Publication Analysis

Top Keywords

neuromyelitis optica
8
years disease
4
remained unchanged
4
fifteen years
4
unchanged direct
4
adem fifteen
4
disease course
4
course revealed
4
nmo meeting
4
status remained
4
typical nmo
4
revealed typical
4
encephalomyelitis adem
4
direct testing
4
diphtheria-pertussis-tetanus dpt
4
dpt vaccination
4
aqp-4-antibodies negative
4
months diphtheria-pertussis-tetanus
4
negative findings
4
vaccination considered
4

Similar Publications